Veterinary Medicines

Cevac Salmovac Lyophilisate for use in drinking water for chickens

Authorised
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014 (adenine and histidine auxotrophic), Live
Download as PDF

Product identification

Medicine name:
Cevac Salmovac Lyophilisate for use in drinking water for chickens
Cevac Salmovac Lyofilisaat voor gebruik in drinkwater
Cevac Salmovac Lyophilisat pour administration dans l'eau de boisson
Cevac Salmovac Lyophilisat zum Eingeben über das Trinkwasser
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014 (adenine and histidine auxotrophic), Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Enteritidis, strain 441/014 (adenine and histidine auxotrophic), Live
    800000000.00
    Colony forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Egg
        3
        week
      • Meat and offal
        6
        week
      • Egg
        6
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • (ID4): 1 Box with 1 Vial (Glass) with 1000 vaccine doses (1000 vaccine doses)
  • (ID3): 1 Box with 12 Vials (Glass) with 5000 vaccine doses (60000 vaccine doses)
  • (ID2): 1 Box with 1 Vial (Glass) with 5000 vaccine doses (5000 vaccine doses)
  • (ID1): 1 Box with 10 Vials(Glass) with 1000 vaccine doses (10000 vaccine doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • IDT Biologika GmbH
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0208/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 2/03/2022
Download
Dutch (PDF)
Published on: 16/09/2025
Download
French (PDF)
Published on: 16/09/2025
Download
German (PDF)
Published on: 16/09/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 16/09/2025
Download
French (PDF)
Published on: 16/09/2025
Download
German (PDF)
Published on: 16/09/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 16/09/2025
Download
French (PDF)
Published on: 16/09/2025
Download
German (PDF)
Published on: 16/09/2025
Download